Yayın:
Development of paclitaxel-loaded liposomal systems with anti-her2 antibody for targeted therapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorGezgin, Seval
dc.contributor.authorBehiye Şenel
dc.contributor.authorEbru Başaran
dc.contributor.authorSeval Gezgin
dc.contributor.orcid0000-0002-5089-6007
dc.contributor.orcid0000-0001-9747-8307
dc.contributor.orcid0000-0003-2104-2069
dc.date.accessioned2025-11-13T11:47:51Z
dc.date.issued2016-05-30
dc.identifier.doihttps://doi.org/10.4314/tjpr.v15i5.1
dc.identifier.endpage895
dc.identifier.issn1596-5996
dc.identifier.issue5
dc.identifier.openalexW4249597374
dc.identifier.startpage895
dc.identifier.urihttps://hdl.handle.net/11421/7989
dc.identifier.urihttps://doi.org/10.4314/tjpr.v15i5.1
dc.identifier.volume15
dc.language.isoen
dc.relation.ispartofTropical Journal of Pharmaceutical Research
dc.rightsopenAccess
dc.subjectLiposome
dc.subjectSonication
dc.subjectCationic liposome
dc.subjectChemistry
dc.subjectChromatography
dc.subjectMTT assay
dc.subjectPaclitaxel
dc.subjectCytotoxicity
dc.subjectPharmacology
dc.subjectCell
dc.subjectBiochemistry
dc.subjectIn vitro
dc.subjectCancer
dc.subjectMedicine
dc.subjectTransfection
dc.subject.sdg3
dc.titleDevelopment of paclitaxel-loaded liposomal systems with anti-her2 antibody for targeted therapy
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5012866347

Dosyalar

Koleksiyonlar

Publications